Delivery Order SPE2DR25D3201-SPE2DR26FT5KN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,327.57 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This firm fixed-price contract, awarded on January 8, 2026, with a completion date of January 9, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the awardee's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $6,330.42 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This non-competitive delivery order, issued on November 24, 2025, represents a firm fixed-price transaction with an ultimate completion date of November 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location. This...
- The Defense Logistics Agency awarded a $4,569.98 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents on January 14, 2026, with completion targeted for January 15, 2026. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $6,229.24 delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed-price contract with an ultimate completion date of January 8, 2026, and was awarded without a set-aside designation through competitive procurement. The products will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order represents a task order executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,730.90 on October 27, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,218.38 to Amerisourcebergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with performance in Conshohocken, Pennsylvania and a completion date of January 15, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was made on January 14, 2026, and represents a task order issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency has awarded a delivery order valued at $40,167.61 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under a larger contract vehicle supporting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,110.14 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of December 30, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $6,330.42. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a non-set-aside competitive award. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $4,712.97 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT5KNDelivery Order
The Defense Logistics Agency awarded a $3,327.57 delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of January 15, 2026. This is a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen Drug Corp's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. Vivitrol (naltrexone for extended-release injection) is an FDA-approved medication used in the treatment of opioid and alcohol use disorders, products which support the military healthcare system's broader therapeutic medication portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/13/26 |